126 related articles for article (PubMed ID: 23262099)
1. [Transcriptional regulation of breast cancer resistance protein].
Wu XG; Peng SB; Huang Q
Yi Chuan; 2012 Dec; 34(12):1529-36. PubMed ID: 23262099
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional modulation of BCRP gene to reverse multidrug resistance by toremifene in breast adenocarcinoma cells.
Zhang Y; Wang H; Wei L; Li G; Yu J; Gao Y; Gao P; Zhang X; Wei F; Yin D; Zhou G
Breast Cancer Res Treat; 2010 Oct; 123(3):679-89. PubMed ID: 19967559
[TBL] [Abstract][Full Text] [Related]
3. Functional cyclic AMP response element in the breast cancer resistance protein (BCRP/ABCG2) promoter modulates epidermal growth factor receptor pathway- or androgen withdrawal-mediated BCRP/ABCG2 transcription in human cancer cells.
Xie Y; Nakanishi T; Natarajan K; Safren L; Hamburger AW; Hussain A; Ross DD
Biochim Biophys Acta; 2015 Mar; 1849(3):317-27. PubMed ID: 25615818
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).
Doyle L; Ross DD
Oncogene; 2003 Oct; 22(47):7340-58. PubMed ID: 14576842
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression.
Nakanishi T; Ross DD
Chin J Cancer; 2012 Feb; 31(2):73-99. PubMed ID: 22098950
[TBL] [Abstract][Full Text] [Related]
6. Survivin up-regulates the expression of breast cancer resistance protein (BCRP) through attenuating the suppression of p53 on NF-κB expression in MCF-7/5-FU cells.
Wang QP; Wang Y; Wang XD; Mo XM; Gu J; Lu ZY; Pan ZL; Zhu YX
Int J Biochem Cell Biol; 2013 Sep; 45(9):2036-44. PubMed ID: 23838170
[TBL] [Abstract][Full Text] [Related]
7. Transcription factor-mediated regulation of the BCRP/
Gorczyca L; Aleksunes LM
Expert Opin Drug Metab Toxicol; 2020 Mar; 16(3):239-253. PubMed ID: 32077332
[No Abstract] [Full Text] [Related]
8. Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene.
Bailey-Dell KJ; Hassel B; Doyle LA; Ross DD
Biochim Biophys Acta; 2001 Sep; 1520(3):234-41. PubMed ID: 11566359
[TBL] [Abstract][Full Text] [Related]
9. [Regulation mechanism of breast cancer resistance protein by toremifene to reverse BCRP-mediated multidrug resistance in breast cancer cells].
Zhang YH; Li G; Yu J; Xu MS; Liu ZX
Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):654-60. PubMed ID: 22340044
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene.
Ee PL; Kamalakaran S; Tonetti D; He X; Ross DD; Beck WT
Cancer Res; 2004 Feb; 64(4):1247-51. PubMed ID: 14973083
[TBL] [Abstract][Full Text] [Related]
11. Progesterone negatively regulates BCRP in progesterone receptor-positive human breast cancer cells.
Wu X; Zhang X; Sun L; Zhang H; Li L; Wang X; Li W; Su P; Hu J; Gao P; Zhou G
Cell Physiol Biochem; 2013; 32(2):344-54. PubMed ID: 23988382
[TBL] [Abstract][Full Text] [Related]
12. Progesterone receptor downregulates breast cancer resistance protein expression via binding to the progesterone response element in breast cancer.
Wu X; Zhang X; Zhang H; Su P; Li W; Li L; Wang Y; Liu W; Gao P; Zhou G
Cancer Sci; 2012 May; 103(5):959-67. PubMed ID: 22348324
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional upregulation of breast cancer resistance protein by 17beta-estradiol in ERalpha-positive MCF-7 breast cancer cells.
Zhang Y; Zhou G; Wang H; Zhang X; Wei F; Cai Y; Yin D
Oncology; 2006; 71(5-6):446-55. PubMed ID: 17878748
[TBL] [Abstract][Full Text] [Related]
14. Progesterone receptor (PR) isoforms PRA and PRB differentially regulate expression of the breast cancer resistance protein in human placental choriocarcinoma BeWo cells.
Wang H; Lee EW; Zhou L; Leung PC; Ross DD; Unadkat JD; Mao Q
Mol Pharmacol; 2008 Mar; 73(3):845-54. PubMed ID: 18042733
[TBL] [Abstract][Full Text] [Related]
15. In vivo and ex vivo regulation of breast cancer resistant protein (Bcrp) by peroxisome proliferator-activated receptor alpha (Pparα) at the blood-brain barrier.
Hoque MT; Shah A; More V; Miller DS; Bendayan R
J Neurochem; 2015 Dec; 135(6):1113-22. PubMed ID: 26465636
[TBL] [Abstract][Full Text] [Related]
16. Valproic Acid-Induced Upregulation of Multidrug Efflux Transporter ABCG2/BCRP via PPAR
Kukal S; Bora S; Kanojia N; Singh P; Paul PR; Rawat C; Sagar S; Bhatraju NK; Grewal GK; Singh A; Kukreti S; Satyamoorthy K; Kukreti R
Mol Pharmacol; 2023 Mar; 103(3):145-157. PubMed ID: 36414374
[TBL] [Abstract][Full Text] [Related]
17. Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein/ABCG2.
Imai Y; Ishikawa E; Asada S; Sugimoto Y
Cancer Res; 2005 Jan; 65(2):596-604. PubMed ID: 15695404
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer resistance protein/ABCG2 is differentially regulated downstream of extracellular signal-regulated kinase.
Imai Y; Ohmori K; Yasuda S; Wada M; Suzuki T; Fukuda K; Ueda Y
Cancer Sci; 2009 Jun; 100(6):1118-27. PubMed ID: 19514121
[TBL] [Abstract][Full Text] [Related]
19. Aryl hydrocarbon receptor is a transcriptional activator of the human breast cancer resistance protein (BCRP/ABCG2).
Tan KP; Wang B; Yang M; Boutros PC; Macaulay J; Xu H; Chuang AI; Kosuge K; Yamamoto M; Takahashi S; Wu AM; Ross DD; Harper PA; Ito S
Mol Pharmacol; 2010 Aug; 78(2):175-85. PubMed ID: 20460431
[TBL] [Abstract][Full Text] [Related]
20. Effect of prostaglandin E2 on multidrug resistance transporters in human placental cells.
Mason CW; Lee GT; Dong Y; Zhou H; He L; Weiner CP
Drug Metab Dispos; 2014 Dec; 42(12):2077-86. PubMed ID: 25261564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
